BLOGS WEBSITE

US Department of Defense: Breast Cancer Research Program (BCRP) – Funding Pre-Announcement

Although funds have not been appropriated for the Department of Defense Breast Cancer Research Program (BCRP), the BCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY17 funding opportunities.

Applications submitted to the FY17 BCRP must address one or more of the following overarching challenges:

  • Prevent breast cancer (primary prevention)
  • Identify determinants of breast cancer initiation, risk, or susceptibility
  • Distinguish deadly from non-deadly breast cancers
  • Conquer the problems of overdiagnosis and overtreatment
  • Identify what drives breast cancer growth; determine how to stop it
  • Identify why some breast cancers become metastatic
  • Determine why/how breast cancer cells lay dormant for years and then re-emerge (recurrence); determine how to prevent recurrence
  • Revolutionise treatment regimens by replacing them with ones that are more effective, less toxic, and impact survival
  • Eliminate the mortality associated with metastatic breast cancer

Anticipated Award Mechanisms

Breakthrough Award

Supports promising research that has the potential to lead to or make breakthroughs in breast cancer.

  • Eligibility: 
    • Investigators at all academic levels (or equivalent)
    • Senior postdoctoral fellows who do not meet the eligibility requirements of the Breakthrough Fellowship Award are encouraged to apply under Funding Levels 1 and 2
  • Funding: There are four levels of funding available. Refer to the pre-announcement press-release for a breakdown of funding options.
  • Duration: Maximum period of performance is 4 years

Breakthrough Fellowship Award

Supports exceptionally talented, “best and brightest” recent doctoral or medical graduates in pursuit of promising research that has the potential to lead to or make breakthroughs in breast cancer.

  • Eligibility:
    • Successfully completed the requirements for a doctoral or medical degree, and
    • Been in the laboratory or clinical research setting in which the proposed research is to be performed for no more than 2 years, and
    • A total of less than 4 years experience in a postdoctoral fellowship or mentored clinical research training program (excludes any clinical residency or fellowship training)
    • Mentor – Must have breast cancer research experience, including current funding and recent publication
  • Funding: Maximum funding of US $300,000 (approx. AUD $397,000) for direct costs (plus indirect costs)
  • Duration: Maximum period of performance is 3 years

Era of Hope Scholar Award

Supports exceptionally talented, creative early-career scientists who have demonstrated that they are the “best and brightest” in their fields.

  • Eligibility: Independent, non-mentored investigators within 6 years of their last training position (e.g., postdoctoral fellowship, medical residency, clinical fellowship) as of the application submission deadline
  • Funding: Maximum funding of US $2.5M (approx AUD $3.3M) for direct costs (plus indirect costs)
  • Duration: Maximum period of performance is 4 years

Innovator Award

Supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field.

  • Eligibility: Associate Professor or above (or equivalent).
  • Funding: Maximum funding of US $5M (approx AUD $6.6M) for direct costs (plus indirect costs)
  • Duration: Maximum period of performance is 4 years

Distinguished Investigator Award

Seeks new paradigms in breast cancer research by supporting investigators who are established and recognised leaders in their field and who propose a fundamental shift from his/her track record of research.

  • Eligibility: Assistant Professor or above (or equivalent) and more than 6 years beyond the PI’s last training position as of the application submission deadline
  • Funding: Maximum funding of US $3M (approx AUD $3.9M) for direct costs (plus indirect costs)
  • Duration: Maximum period of performance is 4 years

Submission

Submission deadlines are not available until the Program Announcement(s) is released.

Further Information

Contact

This entry was posted in News Articles and tagged . Bookmark the permalink.
 

Comments are closed.